Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceJulie Strizki, Nicholas Murgolo, Keith C. Kinek et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 33
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Álvarez, David S. Perlin, Gregory C. Adam et al.|Viruses|2024Cited by 5
Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Bio-Logical and Pharmacological ProfilingNadine Álvarez, David S. Perlin, Gregory C. Adam et al.|Preprints.org|2024Cited by 1